http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Cytek Biosciences Reports First Quarter 2025 Financial Results
-
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
-
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
-
Cytek® Biosciences (CTKB) announces Cytek Muse Micro system
-
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek® Biosciences (CTKB) Reports Prelim FY24 Results
-
Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results
-
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Cytek® Biosciences (CTKB) Announces $50M Share Buyback
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
-
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
-
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
-
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
-
Cytek Biosciences Reports Third Quarter 2024 Financial Results
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
-
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
-
Cytek Announces Resignation of Chief Operating Officer Chris Williams
-
Cytek® Biosciences (CTKB) Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
-
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek Biosciences Reports Second Quarter 2024 Financial Results
-
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
-
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
-
Cytek® Biosciences (CTKB) Announces $50 Million Stock Repurchase Program
-
Cytek Biosciences Announces $50 Million Stock Repurchase Program
-
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
-
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
-
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
-
Cytek Biosciences Reports First Quarter 2024 Financial Results
-
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
-
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
-
Cytek® Biosciences (CTKB) Names William McCombe Chief Financial Officer, 2024 Outlook Reaffirmed
-
Cytek® Biosciences Names William McCombe Chief Financial Officer
-
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
-
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
-
Cytek® Biosciences (CTKB) Announces Preliminary Full Year 2023 Revenue Results
-
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
-
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
-
Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference
-
Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’
-
Cytek Biosciences Reports Third Quarter 2023 Financial Results
-
Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023

